Bloodstream Infections Terminated Phase 4 Trials for Tazobactam (DB01606)

Also known as: Bloodstream Infections (BSI) / Blood Stream Infections / Bloodstream Infection (BSI) / Blood Stream Infection / Blood-stream Infections / Bloodstream Infection / Infection of bloodstream (disorder)

IndicationStatusPhase
DBCOND0056521 (Bloodstream Infections)Terminated4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02176122RCT Meropenem vs Piperacillin-Tazobactam for Definitive Treatment of BSI's Due to Ceftriaxone Non-susceptible Escherichia Coli and Klebsiella Spp.Treatment